Rocco Misiani, MD; Giovanni Mantero, PhD; Piermario Bellavita, MD; Luigi Mori, MSc; Omar Vicari, MSc; Donatella Marchesi, MD; Daniele Primi, PhD
Misiani R, Mantero G, Bellavita P, Mori L, Vicari O, Marchesi D, et al. GB Virus C Infection in Patients with Type II Mixed Cryoglobulinemia. Ann Intern Med. 1997;127:891-894. doi: 10.7326/0003-4819-127-10-199711150-00005
Download citation file:
Published: Ann Intern Med. 1997;127(10):891-894.
Hepatitis C virus (HCV) infection is present in most but not all patients with type II mixed cryoglobulinemia.
To investigate the role of GB virus C (GBV-C) in type II mixed cryoglobulinemia.
Retrospective study of serum and cryoprecipitate samples.
Tertiary care hospital in Bergamo, Italy.
58 cryoglobulinemic patients, 35 of whom were treated with interferon-α.
GB virus C RNA was determined by a reverse-transcription polymerase chain reaction assay done by using primers derived from the conserved GBV-C helicase region.
GB virus C RNA was detected in serum specimens from 23 of 58 cryoglobulinemic patients (40% [95% CI, 27% to 53%]) and 1 of 145 healthy blood donors (0.7%) (P < 0.001). Twenty of the 23 patients with GBV-C RNA were simultaneously infected with HCV. Unlike antibodies to HCV and HCV RNA, GBV-C RNA did not concentrate in cryoprecipitate in patients co-infected with GBV-C and HCV. Furthermore, the therapeutic effectiveness of interferon-α in patients with coinfection was related to the disappearance of HCV RNA but not GBV-C RNA from serum. None of 3 patients with GBV-C infection alone had detectable GBV-C RNA in cryoprecipitate.
Infection with GBV-C, usually associated with HCV, is common in patients with type II mixed cryoglobulinemia but is unlikely to have a primary role in this disease.
Learn more about subscription options.
Register Now for a free account.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only